Q4 2024 Earnings Call Transcript February 4, 2025 Merck & Co., Inc. misses on earnings expectations. Reported EPS is $1.72 ...

Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their use.

The international consulting firm Clarivate makes its bet among the novelties ready for the medicine cabinet this year: three ...

The Illinois Department of Public Health to hold events to focus on heart health. February is American Heart Month, which ...

A data point is marked as “insufficient data” if wastewater samples test negative for a virus (because levels are too low to ...

The novel treatment consists of a single shot which is made of special proteins called antibodies that bind to the site at ...

US health chiefs issued a warning about RSV jabs, which were only launched in Britain last year.In the UK, the condition is ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Sanofi’s jump in earnings comes with an increased emphasis on R&D and vaccines, plus an eye cast toward M&A to shore up its pipeline.

January 2025 marks five years since the beginning of the COVID-19 pandemic that resulted in 1,216,305 American deaths and ...